tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Financial Statements

Compare
3 Followers

MaaT Pharma Financial Overview

MaaT Pharma's market cap is currently €136.89M. The company's EPS TTM is €-0.998; its P/E ratio is -3.40; MaaT Pharma is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 3.22M€ 2.23M€ 1.43M€ 972.00K€ 0.00
Gross Profit€ 1.97M€ 784.00K€ 1.09M€ 806.00K€ -164.00K
Operating Income€ -28.43M€ -19.94M€ -13.56M€ -8.89M€ -7.39M
EBITDA€ -26.34M€ -22.07M€ -13.10M€ -8.57M€ -6.58M
Net Income€ -28.90M€ -19.72M€ -13.71M€ -9.02M€ -5.35M
Balance Sheet
Cash & Short-Term Investments€ 20.22M€ 24.31M€ 35.31M€ 43.30M€ 19.91M
Total Assets€ 38.50M€ 42.93M€ 44.73M€ 49.42M€ 24.28M
Total Debt€ 15.96M€ 14.07M€ 11.36M€ 5.81M€ 6.08M
Net Debt€ -4.20M€ -10.21M€ -23.89M€ -37.50M€ -13.84M
Total Liabilities€ 28.16M€ 22.46M€ 17.91M€ 9.56M€ 8.34M
Stockholders' Equity€ 10.34M€ 20.47M€ 26.81M€ 39.86M€ 15.94M
Cash Flow
Free Cash Flow€ -22.79M€ -19.76M€ -13.27M€ -8.17M€ -6.13M
Operating Cash Flow€ -22.04M€ -18.67M€ -12.61M€ -7.93M€ -5.81M
Investing Cash Flow€ -416.00K€ -440.00K€ -815.00K€ -238.00K€ -523.00K
Financing Cash Flow€ 18.33M€ 8.14M€ 5.36M€ 31.56M€ 20.84M
Currency in EUR

MaaT Pharma Earnings and Revenue History

MaaT Pharma Debt to Assets

MaaT Pharma Cash Flow

MaaT Pharma Forecast EPS vs Actual EPS